- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹43 Cr4,315th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −2.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 4 Jun 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,530
Prism Medico and Pharmacy share news and announcements
816 announcements, routine notices left out, newest first. Page 4 of 17.
Nov 2023
Oct 2023
7 Oct · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.
7 Oct · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
7 Oct · Compliance-57 (5) : intimation after the end of quarter
Sep 2023
Aug 2023
31 Aug · Board meeting
Meeting on 4 Sep 2023: annual general meeting7 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
Jul 2023
20 Jul · Board meeting
Meeting on 20 Jul 2023: increase in authorised capital20 Jul · Fixation Of Date For Closure Of Register Of Members And Share Transfer Books.
14 Jul · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
3 Jul · Compliance-57 (5) : intimation after the end of quarter
Jun 2023
26 Jun · Compliance-57 (4) : Prior intimation to the beginning of the quarter
May 2023
30 May · Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
23 May · Board meeting
Meeting on 30 May 2023: audited results16 May · Announcement under Regulation 30 (LODR)-Meeting Updates
Apr 2023
28 Apr · Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2023.